Arlington Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
3,373
+1,347
+66% +$127K 0.44% 42
2026
Q1
$239K Buy
+2,026
New +$251K 0.48% 32
2024
Q1
Sell
-426
Closed -$84.1K 255
2023
Q4
$84.1K Sell
426
-1,706
-80% -$302K 0.02% 111
2023
Q3
$371K Buy
2,132
+206
+11% +$37.4K 0.15% 67
2023
Q2
$332K Buy
1,926
+1,140
+145% +$197K 0.05% 107
2023
Q1
$131K Buy
786
+453
+136% +$74.2K 0.02% 169
2022
Q4
$48.8K Hold
333
0.01% 220
2022
Q3
$49K Sell
333
-340
-51% -$56.8K 0.02% 195
2022
Q2
$116K Buy
673
+340
+102% +$58.8K 0.04% 145
2022
Q1
$63K Sell
333
-28
-8% -$5.54K 0.02% 228
2021
Q4
$88K Buy
361
+168
+87% +$36.8K 0.02% 216
2021
Q3
$37K Hold
193
0.01% 297
2021
Q2
$36K Hold
193
0.01% 216
2021
Q1
$30K Hold
193
0.01% 283
2020
Q4
$32K Buy
+193
New +$31.4K 0.01% 124
2020
Q2
Sell
-51
Closed -$6K 296
2020
Q1
$6K Buy
+51
New +$6.71K ﹤0.01% 180

Other funds holding ZTS

Arlington Partners's ZTS Position: Q2 2026 in Review

Arlington Partners increased its Zoetis (ZTS) stake by 66% in Q2 2026, buying an estimated $127K and bringing the position to 3,373 shares worth $242K. The position accounts for 0.44% of the portfolio, ranked #42.

Arlington Partners first reported a position in ZTS in Q1 2020 and has held it in 16 quarters since. The position peaked at $371K in Q3 2023. 200 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Arlington Partners held 3,373 shares of Zoetis worth $242K as of Q2 2026.
  • Arlington Partners bought 1,347 Zoetis shares in Q2 2026, an estimated $127K.
  • Zoetis made up 0.44% of Arlington Partners's portfolio in Q2 2026, its #42 holding.
  • Arlington Partners first reported a position in Zoetis in Q1 2020 and has held it in 16 quarters since.
  • Arlington Partners's Zoetis position peaked at $371K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.